Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
135 hedge funds and large institutions have $528M invested in Surmodics in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 10 closing their positions.
90% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 10
29% more capital invested
Capital invested by funds: $411M → $528M (+$118M)
24% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 38
6% more funds holding
Funds holding: 127 → 135 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.94% less ownership
Funds ownership: 90.74% → 89.8% (-0.94%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $216K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.35M |
| 2 |
BlackRock
New York
|
+$2.09M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.05M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.66M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.5M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.51M |
| 3 |
Goldman Sachs
New York
|
-$2.44M |
| 4 |
TI
Trigran Investments
Northbrook,
Illinois
|
-$2.07M |
| 5 |
JP Morgan Chase
New York
|
-$1.4M |
SRDX Hedge Fund Activity: Q2 2020 in Review
135 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2020, worth a combined $528M — up 29% from $411M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new SRDX positions and 10 closed out — a net gain of 9 holders — while 47 added to existing stakes and 38 trimmed.
The largest buyer was Assenagon Asset Management, adding an estimated $3.35M. The largest seller was Millennium Management, exiting entirely with an estimated $5.5M sold.
- 135 institutional investors held Surmodics (SRDX) as of Q2 2020, up from 127 in Q1 2020.
- Funds reported $528M of Surmodics stock for Q2 2020, up 29% quarter-over-quarter.
- 19 funds opened new Surmodics positions in Q2 2020 and 10 closed out, a net change of +9 holders.
- The largest Surmodics buyer in Q2 2020 was Assenagon Asset Management, an estimated $3.35M added.
- The largest Surmodics seller in Q2 2020 was Millennium Management, an estimated $5.5M sold.
Based on aggregated 13F filings for Q2 2020.